Abstract |
The identification of modifiable nutritional risk factors is highly relevant to the development of preventive strategies for neurodegenerative disorders including Parkinson's disease (PD). In this study, adult C57BL/6 mice were fed either a control (CD-12%kcal) or a high-fat diet (HFD-60%kcal) for 8 weeks prior to MPTP exposure, a toxin which recreates a number of pathological features of PD. HFD-fed mice significantly gained weight (+41%), developed insulin resistance and a systemic immune response characterized by an increase in circulating leukocytes and plasmatic cytokines/ chemokines (interleukin-1α, MCP-1, MIP-1α). As expected, the MPTP treatment produced nigral dopaminergic degeneration as evidenced by the loss of striatal dopamine and the decreased number of nigral tyrosine hydroxylase (TH)- and dopamine transporter-expressing neurons (23% and 25%, respectively). However, exposure to HFD exacerbated the effects of MPTP on striatal TH (23%) and dopamine levels (32%), indicating that diet-induced obesity is associated with a reduced capacity of nigral dopaminergic terminals to cope with MPTP-induced neurotoxicity. Since high-fat consumption is commonplace in our modern society, dietary fat intake may represent an important modifiable risk factor for PD.
|
Authors | M Bousquet, I St-Amour, M Vandal, P Julien, F Cicchetti, F Calon |
Journal | Neurobiology of disease
(Neurobiol Dis)
Vol. 45
Issue 1
Pg. 529-38
(Jan 2012)
ISSN: 1095-953X [Electronic] United States |
PMID | 21971528
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Ccl2 protein, mouse
- Chemokine CCL2
- Chemokine CCL3
- Insulin
- Interleukin-1alpha
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Dopamine
|
Topics |
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(pharmacology)
- Animals
- Chemokine CCL2
(blood)
- Chemokine CCL3
(blood)
- Corpus Striatum
(metabolism, pathology)
- Diet, High-Fat
- Dopamine
(metabolism)
- Dopaminergic Neurons
(drug effects, pathology)
- Insulin
(blood)
- Insulin Resistance
- Interleukin-1alpha
(blood)
- Mice
- Nerve Degeneration
(chemically induced, pathology)
- Substantia Nigra
(metabolism, pathology)
|